James Bircher
Chief Operating Officer bij FREELINE THERAPEUTICS HOLDINGS PLC
Profiel
James Bircher is currently the Chief Technical Operations Officer at Freeline Therapeutics Holdings Plc since 2021.
Prior to this, he worked as the Head-Quality at Becton, Dickinson & Co. and as the Senior VP-Quality & Technical Operation at Abeona Therapeutics, Inc. He completed his undergraduate degree from Marshall University.
Actieve functies van James Bircher
| Bedrijven | Functie | Begin |
|---|---|---|
| FREELINE THERAPEUTICS HOLDINGS PLC | Chief Operating Officer | 01-07-2021 |
Eerdere bekende functies van James Bircher
| Bedrijven | Functie | Einde |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
| ABEONA THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van James Bircher
| Marshall University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| ABEONA THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
